Will IMU’s cancer trials cause a surge in stock price?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Imugene Ltd (ASX:IMU) has one of the most exciting stock stories in the biotech industry. Why? Because IMU strives to cure cancer, through a range of new Immuno oncology therapies. […]

Does IMU’s 2020 cancer ‘cure’ clinical trials hold exponential stock growth?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Is there a cure for cancer? A question that instantly makes the scientific world wonder. However, creating a viable solution to cancer is difficult to prove. Because biotechnological and medical […]